Prevalence and predictors of squamous intraepithelial lesions in human immunodeficiency virus positive women in Sagamu, southwest Nigeria
Accepted: 25 April 2022
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Background: Cervical cancer is still a public health problem in many developing countries, like Nigeria. HIV infection makes HPV infections last longer, progress to squamous intraepithelial lesion of the cervix, and eventually lead to invasive cervical cancer. Objective. Find out how often squamous intraepithelial lesions (SIL) happen and what causes them in HIV-positive women in Sagamu, southwest Nigeria.
Methods. A cross-sectional study was done with 165 women with HIV and 165 women without HIV. Pap smears were done on all of the people in the study. The data was looked at with IBM-SPSS Windows v. 23.
Results: Both groups were about the same age and had the same number of children (P=0.194 and P=0.388, respectively). The participants’ average age (SD) was 36.8 (5.6), and the median number of children they had was 3. HIV-positive women were much more likely to have an abnormal cytology smear (24.8%) than HIV-negative women (7.3%) (2 = 18.904, P 0.001). There wasn’t a link between having HIV and the severity of cervical lesions (2 = 3.66, P = 0.162). A CD4 cell count of less than 350 cells/mm3was found to be a strong predictor of an abnormal cervical cytological smear in HIV-positive women (AOR: 25.5; CI: 8.8-73.5; P 0.001).
Conclusion. In Sagamu, Nigeria, the number of HIV-positive women with SIL of the cervix was much higher than the number of HIVnegative women with SIL of the cervix. HIV-positive women, especially those with a low number of CD4 cells, need cervical smear tests more often. This will make sure that pre-invasive lesions are found and treated as soon as possible.
2. Jedy-Agba E, Curado MP, Ogunbiyi O, et al. Cancer incidence in Nigeria: a report from population-based cancer registries. Cancer Epidemiol. 2012;36:e271-8. doi: 10.1016/j.canep.2012.04.007.
3. Mohanty G, Ghosh SN. Risk factors for cancer of cervix and methods for its detection. Arch Gynecol Obstet. 2015: 291: 247-9.
4. Adefuye PO. Knowledge and practice of cervical cancer screening among female professional health workers in a sub urban district of Nigeria. Nig Med Pract 2006; 50: 19-22.
5. Ngune I, Kalembo F, Loessl B, Kivuti-Bitok LW. Biopsychosocial risk factors and knowledge of cervical cancer among young women: A case study from Kenya to inform HPV prevention in Sub-Saharan Africa. PLoS ONE 2020:15:e0237745. https://doi.org/10.1371/journal.pone.0237745
6. Oakeshot P, Aghaizu A, Reid F, et al. Frequency and risk factors for prevalent, incident and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study. BMJ 2012; 344: e 416-8.
7. De Vuyst H, Alemany L, Lacey C, et al. The burden of human papillomavirus infections and related diseases in sub-saharan Africa. Vaccine 2013;31:F32-46. doi: 10.1016/j.vaccine.2012.07.092.
8. Durowade KA, Osagbemi GK, Salaudeen AG, et al. Prevalence and risk factors of cervical cancer among women in an urban community of Kwara State, north central Nigeria. J Prev Med Hyg. 2012;53:213-9.
9. Awofala AA, Ogundele OE. HIV epidemiology in Nigeria. Saudi J Biol Sci 2018,25:697-03. https://doi.org/10.1016/j.sjbs.2016.03.006.
10. Joint United Nations Programme on HIV/AIDS (UNAIDs). The Gap Report: Children and Pregnant Women Living with HIV. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS);2014.
11. Enebe JT, Dim CC, Ozumba BC. Effect of low CD4 count on cervical squamous intraepithelial lesions among HIV positive women in Enugu, South eastern Nigeria. J. Clin Diagn Res 2015; 11:7-10.
12. Dim CC, Ezegwui HU, Ikeme AC, et al. Prevalence of cervical squamous intraepithelial lesions among HIV-positive women in Enugu, South-eastern Nigeria. J Obstet Gynaecol. 2011;31:759-62. doi: 10.3109/01443615.2011.598967.
13. Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013;35:121-6. doi: 10.4103/0253-7176.116232.
14. Bassey G, Jeremiah I, Ikimalo JL, Fiebai PO. Abnormal cervical cytology among HIV positive women in Nigeria. Int J Gynaecol Obstet 2014; 1252:103-6.
15. Nayar R, Wilbur DC. The Pap Test and Bethesda 2014. Acta Cytologica 2015;59:121–32 doi: 10.1159/000381842
16. Muhammad Z, Usman IH, Datti ZA, et al. Incidence and risk factors of cervical dysplasia among human immune deficiency virus positive and human immune deficiency negative women at Aminu Kano Teaching Hospital. Sahel Med J. 2017;20:160-7.
17. Memiah P, Makokha V, Mbuthia W, et al. Epidemiology of Cervical Squamous Intraepithelial Lesions in HIV Infected Women in Kenya: a cross-Sectional Study. Afr J Reprod Health. 2015;19:133-9.
18. Lawal I, Agida TE, Offiong RA, Olawole P.O. Cervical cytology among HIV positive and HIV negative women in tertiary hospital in North central Nigeria. A comparative study. Ann med Health Sci Res. 2017; 7:308-311.
19. Legarth R, Omland LH, Kronborg G, et al. Educational attainment and risk of HIV infection, response to antiretroviral treatment, and mortality in HIV-infected patients. AIDS. 2014;28:387-96. doi: 10.1097/QAD.0000000000000032.
20. McDonald AC, Tergas AI, Kuhn L, et al. Distribution of human papillomavirus genotypes among HIV-Positive and HIV-negative women in Cape Town, South Africa. Front Oncol. 2014;4:48.
21. Ahdieh L, Klein RS, Burk R. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis. 2001;184:682–90.
22. Denslow SA, Rositch AF, Firnhaber C, et al. Incidence and progression of cervical lesions in women with HIV: a systematic global review. Int J STD AIDS. 2014;25:163–77.
23. Ghebre RG, Grover S, Xu MJ, et al. Cervical cancer control in HIV infected women: past, present and future. Gynecol oncol Rep. 2017; 21:101- 8.
24. Dryden-Paterson S, Bvochora-Nsingo M, Suneja G. HIV infection and survival among women with cervical cancer. J Clin Oncol. 2016; 34:3749-57.
25. Wanyoike-Gichuhi J, Kayumba P, Khisa W. Prevalence of cervical cytology abnormalities among HIV infected women at Rwanda military hospital. East Afr Med J. 2014;91:333-40.
26. Swende TZ, Ngwan SD, Swende LT. Prevalence and risk factors for cervical squamous intraepithelial lesions among women infected with HIV in Makurdi, Nigeria. Int J Women’s Health 2012; 4:55-60.
27. Kelly H, Weiss HA, Benavente Y, et al. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis. Lancet HIV. 2018;5:e45-e58. doi: 10.1016/S2352-3018(17)30149-2.
28. De Vuyst H, Mugo NR, Chung MH, et al. Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya. Br J Cancer. 2012;107:1624-30. doi: 10.1038/bjc.2012.441.
29. Durowade KA, Osagbemi GK, Salaudeen AG, et al. Prevalence and risk factors of cervical cancer among women in an urban community of Kwara State, north central Nigeria. J Prev Med Hyg. 2012;53:213-9.
30. Strickler HD, Palefsky JM, Shah KV, et al. Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst 2003; 95: 1062–71.
Copyright (c) 2022 Kehinde Ogunsowo, Adebayo Akadri, Oluwaseyi Odelola, Peter Adefuye, Tessie Shorunmu, Henry Ebili
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.